Family Youth and Services Bureau, 23873-23874 [E9-11816]

Download as PDF Federal Register / Vol. 74, No. 97 / Thursday, May 21, 2009 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Advisory Commission of Childhood Vaccines; Request for Nominations for Voting Members AGENCY: Health Resources and Services Administration, HHS. ACTION: Notice. SUMMARY: The Health Resources and Services Administration (HRSA) is requesting nominations to fill three vacancies on the Advisory Commission on Childhood Vaccines (ACCV). The ACCV was established by Title XXI of the Public Health Service Act (the Act), as enacted by Public Law (Pub. L.) 99– 660 and as subsequently amended, and advises the Secretary of Health and Human Services (the Secretary) on issues related to implementation of the National Vaccine Injury Compensation Program (VICP). DATES: The agency must receive nominations on or before June 22, 2009. ADDRESSES: All nominations are to be submitted to the Director, Division of Vaccine Injury Compensation, Healthcare Systems Bureau (HSB), HRSA, Parklawn Building, Room 11C– 26, 5600 Fishers Lane, Rockville, Maryland 20857. FOR FURTHER INFORMATION CONTACT: Ms. Michelle Herzog, Principal Staff Liaison, Policy Analysis Branch, Division of Vaccine Injury Compensation, HSB, HRSA at (301) 443–0650 or e-mail: mherzog@hrsa.gov. Under the authorities that established the ACCV, the Federal Advisory Committee Act of October 6, 1972 (Pub. L. 92–463) and section 2119 of the Act, 42 U.S.C. 300aa–19, as added by Public Law 99– 660 and amended, HRSA is requesting nominations for three voting members of the ACCV. The ACCV advises the Secretary on the implementation of the VICP. The activities of the ACCV include: recommending changes in the Vaccine Injury Table at its own initiative or as the result of the filing of a petition; advising the Secretary in implementing section 2127 regarding the need for childhood vaccination products that result in fewer or no significant adverse reactions; surveying Federal, State, and local programs and activities related to gathering information on injuries associated with the administration of childhood vaccines, including the adverse reaction reporting requirements dwashington3 on PROD1PC60 with NOTICES SUPPLEMENTARY INFORMATION: VerDate Nov<24>2008 13:08 May 20, 2009 Jkt 217001 of section 2125(b); advising the Secretary on the methods of obtaining, compiling, publishing, and using credible data related to the frequency and severity of adverse reactions associated with childhood vaccines; consulting on the development or revision of the Vaccine Information Statements and recommending to the Director of the National Vaccine Program that vaccine safety research be conducted on various vaccine injuries. The ACCV consists of nine voting members appointed by the Secretary as follows: (1) Three health professionals, who are not employees of the United States Government and have expertise in the health care of children, and the epidemiology, etiology, and prevention of childhood diseases, and the adverse reactions associated with vaccines, at least two shall be pediatricians; (2) three members from the general public, at least two shall be legal representatives (parents or guardians) of children who have suffered a vaccine-related injury or death; and (3) three attorneys, at least one shall be an attorney whose specialty includes representation of persons who have suffered a vaccine-related injury or death, and one shall be an attorney whose specialty includes representation of vaccine manufacturers. In addition, the Director of the National Institutes of Health, the Assistant Secretary for Health, the Director of the Centers for Disease Control and Prevention, and the Commissioner of the Food and Drug Administration (or the designees of such officials) serve as nonvoting ex officio members. Specifically, HRSA is requesting nominations for three voting members of the ACCV representing: (1) A health professional, who has expertise in the health care of children; and the epidemiology, etiology, and prevention of childhood diseases; (2) an attorney whose specialty includes representation of a vaccine manufacturer; and (3) a member of the general public. Nominees will be invited to serve a 3-year term beginning January 1, 2010, and ending December 31, 2012. Interested persons may nominate one or more qualified persons for membership on the ACCV. Nominations shall state that the nominee is willing to serve as a member of the ACCV and appears to have no conflict of interest that would preclude the ACCV membership. Potential candidates will be asked to provide detailed information concerning consultancies, research grants, or contracts to permit evaluation of possible sources of conflicts of interest. A curriculum vitae or resume should be submitted with the nomination. PO 00000 Frm 00036 Fmt 4703 Sfmt 4703 23873 The Department of Health and Human Services has special interest in assuring that women, minority groups, and the physically disabled are adequately represented on advisory committees; and therefore, extends particular encouragement to nominations for appropriately qualified female, minority, or disabled candidates. Dated: May 15, 2009. Alexandra Huttinger, Director, Division of Policy Review and Coordination. [FR Doc. E9–11928 Filed 5–20–09; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Children and Families Family Youth and Services Bureau AGENCY: Family Youth And Services Bureau, ACF, DHHS. ACTION: Notice to Award a Single-Source Replacement Grant. CFDA#: 93.616. Legislative Authority: Section 439 of the Social Security Act, as amended by the Child and Family Services Improvement Act of 2006 (Pub. L. 109– 288) Amount of Award: $292,000. Project Period: April 1, 2009– September 29, 2010. SUMMARY: The Family and Youth Services Bureau (FYSB) awarded a Mentoring Children of Prisoners grant (Grant No. 90CV0343) to Prevent Child Abuse California of North Highlands, CA on September 30, 2007. On October 31, 2008, Prevent Child Abuse California submitted a letter relinquishing their grant. Amador Tuolumne Community Action Agency of Jackson, CA, an eligible non-profit organization, submitted their letter along with their grant application requesting approval as the replacement grantee for the Mentoring Children of Prisoners grant. FYSB has received and reviewed the application from Amador Tuolumne Community Action Agency. Upon finding that the proposed project will be able to carry out objectives originally intended to be completed by Prevent Child Abuse California, this organization has been awarded funds in the amount of $292,000 as the permanent successor grantee. Amador Tuolumne Community Action Agency will continue through a community-based approach to work toward the goal of creating high-quality, one-to-one lasting mentoring E:\FR\FM\21MYN1.SGM 21MYN1 23874 Federal Register / Vol. 74, No. 97 / Thursday, May 21, 2009 / Notices relationships that provide young people, who have an incarcerated parent with caring adult volunteers. Additional information about this program and its purpose can be located on the following Web site: http:// www.acf.hhs.gov/programs/fysb. Contact for Further Information: Gloria Watkins, Family Youth and Services Bureau, 1250 Maryland Ave., SW., Washington, DC 20047. Telephone: (202) 205–9546. E-mail: Gloria.Watkins@acf.hhs.gov. Dated: May 12, 2009. Maiso L. Bryant, Acting Commissioner, Administration on Children, Youth and Families. [FR Doc. E9–11816 Filed 5–20–09; 8:45 am] BILLING CODE P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2009–N–0210] Temporary Deferment of Activities Relating to Medical Device Submissions AGENCY: Food and Drug Administration, HHS. ACTION: Notice. The Food and Drug Administration (FDA) is announcing that the Center for Devices and Radiological Health (CDRH) will be moving from various Rockville, Maryland locations to Building 66 at 10903 New Hampshire Avenue in Silver Spring, Maryland from approximately mid May 2009 until the beginning of August 2009. Offices will progressively move over weekends during this period. Specifically, moves will occur on Friday, Saturday, and Sunday except on holiday weekends. During the period required for relocation of files, equipment, and agency personnel, the Center for Devices and Radiological Health will not officially receive premarket submissions on the Friday of a move weekend and the Monday after a move weekend. FOR FURTHER INFORMATION CONTACT: Marjorie Shulman, Center for Devices and Radiological Health (HFZ–404), Food and Drug Administration, 9200 Corporate Blvd., Rockville, MD 20850, 240–276–4186 or Marjorie.shulman@fda.hhs.gov. dwashington3 on PROD1PC60 with NOTICES SUMMARY: SUPPLEMENTARY INFORMATION: I. Background CDRH is responsible for activities under sections 510, 513, 515, and 520 of VerDate Nov<24>2008 13:08 May 20, 2009 Jkt 217001 the Federal Food, Drug, and Cosmetic Act (the act) (21 U.S.C. 360, 360c, 360e, and 360j). These activities include, but are not limited to: 1. Advising the Director, CDRH, and other FDA officials on all medical device submissions, such as premarket notification submissions under section 510(k) of the act, device classifications under section 513 of the act, premarket approval applications (PMA’s) and product development protocols (PDP’s) under section 515 of the act, and clinical investigations under section 520 of the act; 2. Determining substantial equivalence for premarket notification submissions; 3. Planning, conducting, and coordinating CDRH actions regarding PMA’s, PDP’s, and investigational device exemption approvals, denials, or withdrawals of approval; 4. Monitoring sponsors’ compliance with regulatory requirements; and 5. Conducting a continuing review, surveillance, and medical evaluation of the labeling, clinical experience, and required reports submitted by sponsors holding approved applications. In an effort to consolidate CDRH offices, FDA is moving various CDRH offices from their present Rockville, Maryland locations to Building 66 at 10903 New Hampshire Avenue in Silver Spring, Maryland. Offices will progressively move, during weekends, during this period. Specifically, moves will occur on Friday, Saturday, and Sunday except on holiday weekends. During the period required for relocation of files, equipment, and agency personnel, the agency, specifically the Center for Devices and Radiological Health, will not officially receive submissions on the Friday of a move weekend and the Monday after a move weekend. Although mail will be delivered to a CDRH address during the move, CDRH will not be able to receive it on Fridays and Mondays, and will have limited capacity on Tuesday. Accordingly, mail delivered on Friday or Monday will be logged in on a staggered basis to preserve equity in the order of receipt and manageability of the accumulated workload. Specifically, mail delivered on Friday or Monday will be received on Tuesday and mail delivered on Tuesday will be received by Wednesday. Mail delivered on Wednesdays and Thursdays will remain unaffected. The new mailing address for submissions and updated telephone contact information may be found by accessing www.fda.gov/cdrh/ whiteoakmove. PO 00000 Frm 00037 Fmt 4703 Sfmt 4703 II. Comments Persons who may be affected by this temporary deferment should contact FDA with any questions they may have regarding CDRH’s move to the White Oak, Maryland. These persons should call CDRH’s Division of Small Manufacturers, International, and Consumer Assistance at 800–638–2041 (in Maryland, 240–276–3150). Dated: May 13, 2009. Daniel G. Schultz, Director, Center for Devices and Radiological Health. [FR Doc. E9–11840 Filed 5–20–09; 8:45 am] BILLING CODE 4160–01–S DEPARTMENT OF HOMELAND SECURITY U.S. Customs and Border Protection Accreditation and Approval of Intertek USA, Inc., as a Commercial Gauger and Laboratory AGENCY: U.S. Customs and Border Protection, Department of Homeland Security. ACTION: Notice of accreditation and approval of Intertek USA, Inc., as a commercial gauger and laboratory. SUMMARY: Notice is hereby given that, pursuant to 19 CFR 151.12 and 19 CFR 151.13, Intertek USA, Inc., 101 20th Street South, Texas City, TX 77590, has been approved to gauge and accredited to test petroleum and petroleum products, organic chemicals and vegetable oils for customs purposes, in accordance with the provisions of 19 CFR 151.12 and 19 CFR 151.13. Anyone wishing to employ this entity to conduct laboratory analyses and gauger services should request and receive written assurances from the entity that it is accredited or approved by the U.S. Customs and Border Protection to conduct the specific test or gauger service requested. Alternatively, inquires regarding the specific test or gauger service this entity is accredited or approved to perform may be directed to the U.S. Customs and Border Protection by calling (202) 344–1060. The inquiry may also be sent to cbp.labhq@dhs.gov. Please reference the Web site listed below for a complete listing of CBP approved gaugers and accredited laboratories.http://cbp.gov/ xp/cgov/import/operations_support/ labs_scientific_svcs/ commercial_gaugers/. DATES: The accreditation and approval of Intertek USA, Inc., as commercial gauger and laboratory became effective E:\FR\FM\21MYN1.SGM 21MYN1

Agencies

[Federal Register Volume 74, Number 97 (Thursday, May 21, 2009)]
[Notices]
[Pages 23873-23874]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-11816]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Administration for Children and Families


Family Youth and Services Bureau

AGENCY: Family Youth And Services Bureau, ACF, DHHS.

ACTION: Notice to Award a Single-Source Replacement Grant.

-----------------------------------------------------------------------

    CFDA#: 93.616.
    Legislative Authority: Section 439 of the Social Security Act, as 
amended by the Child and Family Services Improvement Act of 2006 (Pub. 
L. 109-288)
    Amount of Award: $292,000.
    Project Period: April 1, 2009-September 29, 2010.

SUMMARY: The Family and Youth Services Bureau (FYSB) awarded a 
Mentoring Children of Prisoners grant (Grant No. 90CV0343) to Prevent 
Child Abuse California of North Highlands, CA on September 30, 2007. On 
October 31, 2008, Prevent Child Abuse California submitted a letter 
relinquishing their grant. Amador Tuolumne Community Action Agency of 
Jackson, CA, an eligible non-profit organization, submitted their 
letter along with their grant application requesting approval as the 
replacement grantee for the Mentoring Children of Prisoners grant. FYSB 
has received and reviewed the application from Amador Tuolumne 
Community Action Agency. Upon finding that the proposed project will be 
able to carry out objectives originally intended to be completed by 
Prevent Child Abuse California, this organization has been awarded 
funds in the amount of $292,000 as the permanent successor grantee.
    Amador Tuolumne Community Action Agency will continue through a 
community-based approach to work toward the goal of creating high-
quality, one-to-one lasting mentoring

[[Page 23874]]

relationships that provide young people, who have an incarcerated 
parent with caring adult volunteers.
    Additional information about this program and its purpose can be 
located on the following Web site: http://www.acf.hhs.gov/programs/fysb.
    Contact for Further Information: Gloria Watkins, Family Youth and 
Services Bureau, 1250 Maryland Ave., SW., Washington, DC 20047. 
Telephone: (202) 205-9546. E-mail: Gloria.Watkins@acf.hhs.gov.

    Dated: May 12, 2009.
Maiso L. Bryant,
Acting Commissioner, Administration on Children, Youth and Families.
[FR Doc. E9-11816 Filed 5-20-09; 8:45 am]
BILLING CODE P